0001077183-22-000140.txt : 20220812 0001077183-22-000140.hdr.sgml : 20220812 20220812163440 ACCESSION NUMBER: 0001077183-22-000140 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220812 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20220812 DATE AS OF CHANGE: 20220812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 221160700 BUSINESS ADDRESS: STREET 1: 9490 NEOGENOMICS WAY CITY: FORT MYERS STATE: FL ZIP: 33912 BUSINESS PHONE: 2397680600 MAIL ADDRESS: STREET 1: 9490 NEOGENOMICS WAY CITY: FORT MYERS STATE: FL ZIP: 33912 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 8-K 1 neo-20220812.htm 8-K neo-20220812
0001077183FALSE00010771832022-08-122022-08-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549 
 
FORM 8-K  
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
August 12, 2022
 
NEOGENOMICS, INC.
(Exact name of registrant as specified in its charter) 
 
Nevada
001-35756
74-2897368
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)

 
9490 NeoGenomics Way,Fort Myers,Florida33912
(Address of principal executive offices)(Zip Code)
(239) 768-0600
(Registrant’s telephone number, including area code) 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered
Common stock ($0.001 par value)NEOThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 



Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Amendment to CEO Employment Agreement
On August 12, 2022, NeoGenomics, Inc. (the “Company”) entered into an amendment to the employment agreement between the Company and Mr. Christopher Smith, its incoming Chief Executive Officer, effective as of August 15, 2022 (the “Amendment”). The Amendment provides for an additional inducement award in the form of restricted stock with a target value of approximately $3,350,000 and additional relocation benefits in the amount of $800,000. All other terms of the original employment agreement (the “Employment Agreement”) are unchanged.
The foregoing description of the terms of the Amendment is qualified in its entirety by the terms of the Amendment, which will be filed as an exhibit to the Company’s next Quarterly Report on Form 10-Q, and the Employment Agreement, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 21, 2022.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
NEOGENOMICS, INC.
By:/s/ William B. Bonello
Name:William B. Bonello
Title:Chief Financial Officer
Date:August 12, 2022


 EX-101.SCH 2 neo-20220812.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 neo-20220812_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Trading Symbol Trading Symbol Document Period End Date Document Period End Date Soliciting Material Soliciting Material Document Type Document Type City Area Code City Area Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name Entity Address, Address Line Two Entity Address, Address Line Two Local Phone Number Local Phone Number Entity Address, City or Town Entity Address, City or Town Cover [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 4 neo-20220812_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover
Aug. 12, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 12, 2022
Entity Registrant Name NEOGENOMICS, INC.
Entity Central Index Key 0001077183
Amendment Flag false
Entity Incorporation, State or Country Code NV
Entity File Number 001-35756
Entity Tax Identification Number 74-2897368
Entity Address, Address Line One 9490 NeoGenomics Way,
Entity Address, City or Town Fort Myers,
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33912
City Area Code (239)
Local Phone Number 768-0600
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock ($0.001 par value)
Trading Symbol NEO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 neo-20220812_htm.xml IDEA: XBRL DOCUMENT 0001077183 2022-08-12 2022-08-12 0001077183 false 8-K 2022-08-12 NEOGENOMICS, INC. NV 001-35756 74-2897368 9490 NeoGenomics Way, Fort Myers, FL 33912 (239) 768-0600 false false false false Common stock ($0.001 par value) NEO NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 22 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://neogenomics.com/role/Cover Cover Cover 1 false false All Reports Book All Reports neo-20220812.htm neo-20220812.xsd neo-20220812_lab.xml neo-20220812_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "neo-20220812.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "neo-20220812.htm" ] }, "labelLink": { "local": [ "neo-20220812_lab.xml" ] }, "presentationLink": { "local": [ "neo-20220812_pre.xml" ] }, "schema": { "local": [ "neo-20220812.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "neo", "nsuri": "http://neogenomics.com/20220812", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "neo-20220812.htm", "contextRef": "i0d0a12bc698d4f4e944709ac9e2b95e1_D20220812-20220812", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://neogenomics.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "neo-20220812.htm", "contextRef": "i0d0a12bc698d4f4e944709ac9e2b95e1_D20220812-20220812", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://neogenomics.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001077183-22-000140-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001077183-22-000140-xbrl.zip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